ArticleFrontiers in oncology2022

SDK1-ALK Fusion in a Lung Adenocarcinoma Patient With Excellent Response to ALK Inhibitor Treatment: A Case Report.

Lin Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.